The prognostic impact of cigarette smoking on patients with non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 6, Issue 4, 2011, Pages 735-742

  Maeda, Ryo ^a   Yoshida, Junji ^a   Ishii, Genichiro ^a   Hishida, Tomoyuki ^a   Nishimura, Mitsuyo ^a   Nagai, Kanji ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Adenocarcinoma; Cigarette smoking; Non small cell lung cancer; Recurrence; Thoracic surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 79953026245     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318208e963     Document Type: Article

References (31)

1. Pfeifer GP, Denissenko MF, Olivier M, et al. Tobacco smoke carcino-gens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 2002;21:7435-7451. (Pubitemid 35305599)
2. Stellman SD, Resnicow K. Tobacco smoking, cancer and social class. IARC Sci Publ 1997:229-250.
3. Margetts BM, Jackson AA. Interactions between people's diet and their smoking habits: the dietary and nutritional survey of British adults. BMJ 1993;307:1381-1384. (Pubitemid 23341666)
4. Ogle KS, Swanson GM, Woods N, et al. Cancer and comorbidity: redefining chronic diseases. Cancer 2000;88:653-663. (Pubitemid 30056943)
5. Meliska CJ, Stunkard ME, Gilbert DG, et al. Immune function in cigarette smokers who quit smoking for 31 days. JAllergy Clin Immunol 1995;95:901-910.
6. Hanagiri T, Sugio K, Mizukami M, et al. Significance of smoking as a postoperative prognostic factor in patients with non-small cell lung cancer. J Thorac Oncol 2008;3:1127-1132.
7. Wu YC, Lin CF, Hsu WH, et al. Long-term results ofpathological stage I non-small cell lung cancer: validation of using the number of totally removed lymph nodes as a staging control. Eur J Cardiothorac Surg 2003;24:994-1001.
8. Sobue T, Yamamoto S, Hara M, et al.; JPHC Study Group. Japanese Public Health Center. Cigarette smoking and subsequent risk of lung cancer by histologic type in middle-aged Japanese men and women: the JPHC study. Int J Cancer 2002;99:245-251.
9. Nordquist LT, Simon GR, Cantor A, et al. Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. Chest 2004;126:347-351. (Pubitemid 39093415)
10. Sardari Nia P, Weyler J, Colpaert C, et al. Prognostic value of smoking status in operated non-small cell lung cancer. Lung Cancer 2005;47: 351-359. (Pubitemid 40248739)
11. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;2:706-714. (Pubitemid 47357522)
12. Travis WD, Brambilla E, Muller-Hermelink HK, et al. World Health Organization Classification of Tumors: Pathology and Genetics of Tu-mors of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press, 2004.
13. Harpole DH Jr, Herndon JE II, Wolfe WG, et al. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. Cancer Res 1995;55:51-56.
14. Tammemagi MC, McLaughlin JR, Mullen JB, et al. A study of smoking, p53 tumor suppressor gene alterations and non-small cell lung cancer. Ann Epidemiol 2000;10:176-185. (Pubitemid 30171275)
15. Langendijk JA, Thunnissen FB, Lamers RJ, et al. The prognostic significance of accumulation ofp53 protein in stage III non-small cell lung cancer treated by radiotherapy. Radiother Oncol 1995;36:218-224.
16. Guo NL, Tosun K, Horn K. Impact and interactions between smoking and traditional prognostic factors in lung cancer progression. Lung Cancer 2009;66:386-392.
17. Bryant A, Cerfolio RJ. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer. Chest 2007;132:185-192. (Pubitemid 47068220)
18. Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 2002;122:1037-1057.
19. Westra WH, Slebos RJ, Offerhaus GJ, et al. K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung. Cancer 1993;72:432-438. (Pubitemid 23193449)
20. Suzuki H, Takahashi T, Kuroishi T, et al. p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res 1992;52:734-736.
21. Tollerud DJ, Clark JW, Brown LM, et al. Association of cigarette smoking with decreased numbers of circulating natural killer cells. Am Rev Respir Dis 1989;139:194-198. (Pubitemid 19030444)
22. Lee JS, Yoon A, Kalapurakal SK, et al. Expression ofp53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor. J Clin Oncol 1995;13:1893-1903.
23. Pezzella F, Turley H, Kuzu I, et al. bcl-2 protein in non-small-cell lung carcinoma. NEngl JMed 1993;329:690-694. (Pubitemid 23252262)
24. Hsu HS, Wen CK, Tang YA, et al. Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSH2 deregulation and is a poor prognostic factor in nonsmoking lung cancer. Clin Cancer Res 2005;11:5410-5416.
25. Sato M, Shames DS, Gazdar AF, et al. A translational view of the molecularpathogenesis of lung cancer. JThorac Oncol2007;2:327-343. (Pubitemid 47181718)
26. Wang CY, Huang MS, Huang MH, et al. Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer. J Surg Res 2010;163: e45-e50.
27. Dhital K, Saunders CA, Seed PT, et al. [(18)F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer. Eur J Cardiothorac Surg 2000;18:425-428.
28. Al-Sarraf N, Gately K, Lucey J, et al. Clinical implication and prognos-tic significance of standardized uptake value of primary non-small cell lung cancer on positron emission tomography: analysis of 176 cases. Eur J Cardiothorac Surg 2008;34:892-897.
29. Higashiyama M, Kodama K, Yokouchi H, et al. Prognostic value of bronchiolo-alveolar carcinoma component of small lung adenocarci-noma. Ann Thorac Surg 1999;68:2069-2073. (Pubitemid 30027827)
30. Sakao Y, Miyamoto H, Sakuraba M, et al. Prognostic significance of a histologic subtype in small adenocarcinoma of the lung: the impact of nonbronchioloalveolar carcinoma components. Ann Thorac Surg 2007; 83:209-214. (Pubitemid 44917878)
31. Anami Y, Iijima T, Suzuki K, et al. Bronchioloalveolar carcinoma (lepidic growth) component is a more useful prognostic factor than lymph node metastasis. J Thorac Oncol 2009;4:951-958.